Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathophysiology of coronary spasm]

K Kugiyama1, H Yasue

  • 1Division of Cardiology, Kumamoto University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 31, 1998
PubMed
Summary

Coronary spastic angina patients show deficient nitric oxide (NO) release, impairing artery dilation. This NO deficiency contributes to abnormal blood vessel responses, impacting coronary tone during stress.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic relationships between Japanese native and commercial breeds using 70 chicken autosomal SNP genotypes by the DigiTag2 assay.

Animal genetics·2012
Same author

A high-resolution comparative map of porcine chromosome 4 (SSC4).

Animal genetics·2011
Same author

Existence of Pink1 antisense RNAs in mouse and their localization.

Cytogenetic and genome research·2010
Same author

Molecular characterization of the DDX3Y gene and its homologs in cattle.

Cytogenetic and genome research·2009
Same author

Assignment of 128 genes localized on human chromosome 14q to the IMpRH map.

Animal genetics·2009
Same author

A 4,103 marker integrated physical and comparative map of the horse genome.

Cytogenetic and genome research·2008

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Function Research
  • Nitric Oxide Biology

Context:

  • Coronary spastic angina (CSA) is characterized by abnormal coronary artery constriction.
  • Endothelial dysfunction, particularly impaired nitric oxide (NO) production, is implicated in cardiovascular diseases.
  • Previous studies suggest a role for NO in regulating coronary tone, but its specific involvement in CSA remains unclear.

Purpose:

  • To investigate the role of endothelial nitric oxide (NO) in the impaired vasodilation observed in coronary arteries of patients with coronary spastic angina (CSA).
  • To assess basal and stimulated NO release in spasm-prone coronary arteries.
  • To evaluate the impact of NO deficiency on flow-dependent dilation and vascular responsiveness to vasoactive agents in CSA.

Summary:

  • Patients with coronary spastic angina exhibit deficient basal and stimulated nitric oxide (NO) release in affected arteries.
  • Flow-dependent coronary dilation was significantly reduced in spasm arteries compared to controls.
  • Administration of L-NMMA (a nitric oxide synthase inhibitor) impaired flow-dependent dilation in control arteries but not in spasm arteries, indicating impaired endothelial NO bioactivity in CSA.

Impact:

  • Findings suggest that impaired endothelial NO bioactivity is a key factor contributing to reduced flow-dependent dilation in coronary arteries of CSA patients.
  • This deficiency in NO may lead to altered vascular sensitivity to vasodilators and vasoconstrictors, potentially increasing coronary tone during physiological stress.
  • The study highlights a potential therapeutic target for managing coronary vasospasm by addressing endothelial NO dysfunction.

Related Experiment Videos